These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 599124)

  • 21. The use of doxycycline, mezlocillin and clotrimazole in cell culture media as contamination prophylaxis.
    Hövel H; Frieling KH
    Dev Biol Stand; 1987; 66():23-8. PubMed ID: 3582752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro activity of 9 antimicrobials against Bacteroides fragilis].
    Betriu Cabecerán C; Cogollos Agruña R; García Alonso G; Agra Valero M
    Rev Clin Esp; 1988 Feb; 182(3):134-6. PubMed ID: 3285381
    [No Abstract]   [Full Text] [Related]  

  • 23. A new chromogenic medium for isolation of Bacteroides fragilis suitable for screening for strains with antimicrobial resistance.
    Tierney D; Copsey SD; Morris T; Perry JD
    Anaerobe; 2016 Jun; 39():168-72. PubMed ID: 27060277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaerobic susceptibility tests: differences between disc diffusion, agar dilution and broth microdilution test results.
    Barry AL
    J Antimicrob Chemother; 1990 May; 25(5):875-7. PubMed ID: 2373671
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro effects of cefotetan against Bacteroides of the fragilis group].
    Privitera G; Ortisi G; Rossi R; Vigo B
    G Ital Chemioter; 1985; 32(2):371-4. PubMed ID: 3869116
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sensitivity of Bacteroides fragilis to antibiotics].
    Gaspar MC; Ponte MC; Soriano F
    Rev Clin Esp; 1981 Oct; 163(2):111-2. PubMed ID: 7330342
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains.
    Betriu C; Sánchez A; Palau ML; Gómez M; Picazo JJ
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2372-4. PubMed ID: 11451700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sensitivity of Bacteroides of the fragilis group to various antibiotics].
    de la Torre Misiego F; Betriú Cabecerán C; López Bartolomé O; Rodriguez Avial C; López Doriga
    Rev Clin Esp; 1981 Dec; 163(6):387-90. PubMed ID: 7342200
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacteroides fragilis and nitroimidazoles.
    Ferguson IR; Smith LL
    J Antimicrob Chemother; 1976 Jun; 2(2):220-1. PubMed ID: 956086
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of gentamicin on Bacteroides fragilis].
    García Hierro P; Ponte Miramontes MC; Soriano García F
    Rev Clin Esp; 1980 Nov; 159(3):177-9. PubMed ID: 7465896
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Susceptibility of Bacteroides fragilis to spectinomycin.
    Okubadejo OA
    J Antimicrob Chemother; 1975 Sep; 1(3):347-8. PubMed ID: 126984
    [No Abstract]   [Full Text] [Related]  

  • 33. The activity of nitro-compounds against Bacteroides fragilis is related to their electron affinity.
    Reynolds AV
    J Antimicrob Chemother; 1981 Aug; 8(2):91-9. PubMed ID: 7275885
    [No Abstract]   [Full Text] [Related]  

  • 34. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.
    Soriano F; Ponte MC; Gaspar MC
    J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].
    Borobio MV; Domínguez MC; Pallares JA; Perea EJ
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative in vitro activity of 4 cephalosporins on Bacteroides fragilis].
    Castillo AM; Fernández-Crehuet M; Ocete MD; Liébana JJ; Cueto A; Maroto MC; Piédrola MG
    Med Clin (Barc); 1986 Apr; 86(15):624-6. PubMed ID: 3724274
    [No Abstract]   [Full Text] [Related]  

  • 37. Bacteroides fragilis infections of the urinary tract.
    Garcia JA; Prieto J; Garcia JE; Saenz MC
    J Antimicrob Chemother; 1977 Sep; 3(5):521-2. PubMed ID: 903332
    [No Abstract]   [Full Text] [Related]  

  • 38. [Appearance of metronidazole resistance in Bacteroides fragilis].
    Chardon H; Ratignier A; Luneau R; Garrigues B
    Nouv Presse Med; 1977 Jun; 6(24):2165. PubMed ID: 905136
    [No Abstract]   [Full Text] [Related]  

  • 39. Bactericidal activity of metronidazole, tinidazole and ornidazole against Bacteroides fragilis in vitro.
    Jokipii L; Jokipii AM
    J Antimicrob Chemother; 1977 Nov; 3(6):571-7. PubMed ID: 599119
    [No Abstract]   [Full Text] [Related]  

  • 40. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.